{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-012812","form_type":"8-K","ticker":"MBOT","cik":"0000883975","company_name":"Microbot Medical Inc.","filed_at":"2026-03-26T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.911848+00:00","generated_at":"2026-05-15T08:57:03.448465+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"confidence":"high","headline":"Emory performs first robotic PAE and Y-90 mapping using Microbot's LIBERTY System","bullets":["World's first robotic prostate artery embolization (PAE) for BPH performed with LIBERTY at Emory.","First robotic Y-90 radioembolization mapping for liver cancer completed using the same system.","LIBERTY is FDA-cleared, single-use, remotely operated robotic system for peripheral endovascular procedures.","Limited Market Release started November 2025; Full Market Release planned for April 2026 at SIR conference.","BPH affects approximately 40 million men in the U.S.; LIBERTY aims to become standard of care for PAE."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-012812","json":"https://secwatch.observer/filing/0001493152-26-012812.json","markdown":"https://secwatch.observer/filing/0001493152-26-012812.md","text":"https://secwatch.observer/filing/0001493152-26-012812.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/883975/000149315226012812/0001493152-26-012812-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/883975/000149315226012812/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T08:57:03.448465+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}